Physician profile
Timothy G Cornitius
NPI 1679554133
$1,427.20
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.59 · 2020: $389 · 2021: $318 · 2022: $215 · 2023: $259 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $453.98 | 2019-2024 | Skyrizi, Rinvoq |
| Amgen INC. | $241.38 | 2019-2024 | Otezla |
| Lilly USA, LLC | $189.80 | 2019-2023 | Taltz, Olumiant |
| Janssen Biotech, INC. | $175.97 | 2020-2024 | Simponi, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $93.14 | 2020-2023 | Blu-U |
| Sanofi-Aventis U.S. LLC | $72.00 | 2021 | |
| Novartis Pharmaceuticals Corporation | $55.64 | 2022-2024 | |
| Genzyme Corporation | $31.77 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.23 | 2023-2024 | Sotyktu |
| Genentech USA, INC. | $28.20 | 2021-2022 | |
| Galderma Laboratories, L.P. | $16.46 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.24 | 2024 | Arazlo |
| Celgene Corporation | $13.72 | 2019 | |
| Dermira, INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cornitius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.